Gufic Biosciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Gufic Biosciences Ltd · Outcome · 15 Nov 2026, 1:41 am
Gufic Biosciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 28,827 (+21.6% YoY | +10.5% QoQ) ■ EBITDA: 4,849 (+28.1% YoY | +4.1% QoQ) ■ EBITDA Margin (%): 16.8 (+86 bps YoY | -105 bps QoQ) ■ PAT: 2,347 (+39.5% YoY | +5.2% QoQ) ■ EPS (INR): 2.34 (+39.3% YoY | +5.4% QoQ)
Original exchange filing (PDF)
More announcements from Gufic Biosciences Ltd
- Intimation of Audio Recording of Earnings Conference Call held on November 16, 2026 at 04:30 p.m. is attached herewith · 17 Nov 2026
- Investor Presentation is attached herewith · 15 Nov 2026
- Intimation for appointment of Additional Director (Non-Executive Independent Director) of the Company is attached herewith. · 15 Nov 2026
- Gufic Biosciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 15 Nov 2026
- Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year Ended September 30, 2026 is attached herewith · 15 Nov 2026
- Intimation of Environmental, Social and Governance (''ESG'') Rating is attached herewith · 13 Nov 2026
- Intimation of Earnings Conference Call scheduled to be held on November 16, 2026 is attached herewith · 16 Nov 2026
- Gufic Biosciences Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 14 Nov 2026
